September:Here's a link to a one-year RCT chart.
https://finance.yahoo.com/echarts?s=RCT.V+Interactive#symbol=RCT.V;range=
On October 1, 2010 RCT recently topped at 0.15 CA. (In the US, RCTFF's recent top was on September 28 at 0.141 US.)
The chart shows a stark peak at the end of September. It's probably pretty safe to conclude that the peak is a result of RCT's annual report being published. This year we are on the same company release-of-information schedule, and by the time we have the coming report it will easily be five months from the last release. This has been happening every year. The coming report will compare things about the past two years, and give us final quarter information through May. We won't have 1st quarter results through August until the end of October.
I think the October release in many ways, is a big one too, but I have to say there is not much that is attractive to this unorthodox system RCT has for filing its reports. However, we are, right now, entering into the "knowing" time of the year for RCT. It looks like, from the chart, that the news in October of last year was nothing to motivate investors, and the stock declined for the rest of the year. Hopefully we will have good news in the September and October reports, and the SP will stay up. I think that is very likely, just based on how the POG will impact their revenue.
My expectations are very bullish. I'm thinking a lot like Trend and others that the report will include numbers on increased revenues, higher productions, almost zero debt, expanded resources, development news, mill capacity increase progress, and some light being shed on why the silver recoveries have come down from the 80% that they once were.
Now, what the warrants, shares issued, and fully diluted numbers mean are something I'd like to see discussed here.
Here again are the details on the Warrants coming due:
82,859,960 shares reserved at an exercise price of 0.20 with an expiry date of November 25, 2011.
Although it appears unlikely, there are advantages to seeing these exercised. The advantage is that the share price would have to be high enough for it to make sense. The warrants were issued to Mackenzie at no extra cost, as part of the 12M+ PP back in 2010. The full amount that would come into the company if they all were exercised would be $16.5M+. The amount of shares issued would increase, but the share price would have be high enough so the dilution would be tolerable as the value of the company would take a leap up. The advantage to seeing the warrants expire is that the potential for the amount of shares of the company to increase would be largely reduced. Right now these are the share numbers:
Issued and Outstanding:136,459,771
Options: 10,452,500
Warrants: 87,459,980
Fully Diluted:234,372,251
If the 11-25-11 warrants expire without exercise the fully diluted number will drop to about 147M. So what's the better outcome? Will there be some move to send the SP of RCT higher to enable the money to come into the company? Will the SP be held down to avoid dilution?
Right now Mackenzie is underwater after having paid .15 per share for their 82M+ shares. They lose nothing on seeing the warrants expire but their pride,and I'm sure they'd like to see the SP come up.
I suppose it could go either way, but the point has been made that there is not much downside to investing here. Outside of a mill shutdown, labor strike, or another institution dumping, there's not much else that could send the SP south. Right now it takes 4.6 cents US to by one RCT share. In the whole scheme of things, I think it takes not that much money to buy all the RCT shares that are being offered at the price point and in the volume of what Kentre has been sharing info about. Going into this time where we are going to be finding out more on RCT, a vested institution, a new institution, or an individual with deep pockets could put those shares away in one move and dramatically change the market dynamics for RCT, and considering all that RCT has going for it, I consider that a real possibility.